CureVac sues BioNTech over mRNA technology

Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid (mRNA) technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Medtech firm faces lawsuit over COVID–19 design

2 August 2022 Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Big Pharma

Big pharma firm hits back in COVID-19 tech dispute

6 September 2022 CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid

Big Pharma

Pfizer and partner hit back in COVID-19 vaccine dispute

8 December 2022 Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.

More on this story

Medtech

Medtech firm faces lawsuit over COVID–19 design

2 August 2022 Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Big Pharma

Big pharma firm hits back in COVID-19 tech dispute

6 September 2022 CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid

Big Pharma

Pfizer and partner hit back in COVID-19 vaccine dispute

8 December 2022 Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.

More on this story

Medtech

Medtech firm faces lawsuit over COVID–19 design

2 August 2022 Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Big Pharma

Big pharma firm hits back in COVID-19 tech dispute

6 September 2022 CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid

Big Pharma

Pfizer and partner hit back in COVID-19 vaccine dispute

8 December 2022 Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.